Brandinium

Trademark search for:

AMBIRIX

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2013-11-26 — Application filed
  • 2013-11-29 — Application filed
  • 2013-12-10 — Application filed
  • 2014-01-21 — Final disposition recorded
  • 2014-01-21 — Final disposition recorded
  • 2014-01-21 — Assigned to examiner
  • 2014-01-21 — Final disposition recorded
  • 2014-05-05 — Office action issued
  • 2014-05-15 — Assigned to lie
  • 2014-05-28 — Approved for pub - principal register
  • 2014-05-28 — Teas/email correspondence entered
  • 2014-05-28 — Correspondence received in law office
  • 2014-05-31 — Law office publication review completed
  • 2014-06-18 — Notification of notice of publication e-mailed
  • 2014-07-08 — Published for opposition
  • 2014-07-08 — Official gazette publication confirmation e-mailed
  • 2014-07-16 — Extension of time to oppose received
  • 2014-09-25 — Application abandoned
  • 2014-09-26 — Application abandoned
  • 2014-09-26 — Application abandoned
  • 2014-09-26 — Final status recorded

Owner Information

GlaxoSmithKline Biologicals S.A.
Rixensart BE
GlaxoSmithKline Biologicals S.A.
Rixensart BE

Correspondent

ANGELA L. WILSON GLAXOSMITHKLINE
5 MOORE DR
RESEARCH TRIANGLE PARK, NC 27709-0183
UNITED STATES

Filing Details

Filing Date:
2013-11-26
Status Date:
2014-09-26
Category:
Pharmaceuticals
Filing Year:
1996

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.